Cargando…

Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials

There is currently no effective pharmacological therapy to improve the cognitive dysfunction of individuals with Down syndrome (DS). Due to the overexpression of several chromosome 21 genes, cellular and systemic oxidative stress (OS) is one of the most important neuropathological processes that con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rueda Revilla, Noemí, Martínez-Cué, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464577/ https://www.ncbi.nlm.nih.gov/pubmed/32756318 http://dx.doi.org/10.3390/antiox9080692

Ejemplares similares

Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome
por: Martínez-Cué, Carmen, et al.
Publicado: (2020)

Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
por: Rueda, Noemí, et al.
Publicado: (2012)

Oxidative-Stress-Associated Proteostasis Disturbances and Increased DNA Damage in the Hippocampal Granule Cells of the Ts65Dn Model of Down Syndrome
por: Puente-Bedia, Alba, et al.
Publicado: (2022)

Nuclear Reorganization in Hippocampal Granule Cell Neurons from a Mouse Model of Down Syndrome: Changes in Chromatin Configuration, Nucleoli and Cajal Bodies
por: Puente-Bedia, Alba, et al.
Publicado: (2021)

Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome?
por: Martínez-Cué, Carmen, et al.
Publicado: (2022)

Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
por: Vidal, Verónica, et al.
Publicado: (2021)

Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
por: García-Cerro, Susana, et al.
Publicado: (2014)

Cellular Senescence in Neurodegenerative Diseases
por: Martínez-Cué, Carmen, et al.
Publicado: (2020)

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
por: Baumer, Nicole T., et al.
Publicado: (2022)

Evidences from Clinical Trials in Down Syndrome: Diet, Exercise and Body Composition
por: Martínez-Espinosa, Rosa María, et al.
Publicado: (2020)

Down syndrome is an oxidative phosphorylation disorder
por: Bayona-Bafaluy, M. Pilar, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Properties of Mastiha: A Review of Preclinical and Clinical Studies
por: Papada, Efstathia, et al.
Publicado: (2019)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy
por: Liu, Yifan, et al.
Publicado: (2023)

Preclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides—A Review
por: Jensen, Ida-Johanne, et al.
Publicado: (2016)

Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
por: Delgado-Minjares, Karen M., et al.
Publicado: (2021)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Natural Antioxidant Application on Fat Accumulation: Preclinical Evidence
por: Roy, Proshanta, et al.
Publicado: (2021)

A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
por: Srivastava, Siddhartha, et al.
Publicado: (2019)

Clinical practice: The care of children with Down syndrome
por: Weijerman, Michel E., et al.
Publicado: (2010)

CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
por: Zhang, Zhongkun, et al.
Publicado: (2021)

Down syndrome and leukemia: from basic mechanisms to clinical advances
por: Baruchel, André, et al.
Publicado: (2023)

DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?
por: Ahmad, Sarfraz, et al.
Publicado: (2012)

Radiation nanosensitizers in cancer therapy—From preclinical discoveries to the outcomes of early clinical trials
por: Bilynsky, Colette, et al.
Publicado: (2021)

Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
por: Yee, Tiffany, et al.
Publicado: (2022)

Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials
por: Rozkiewicz, Dariusz, et al.
Publicado: (2023)

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
por: Behr, Guilherme A., et al.
Publicado: (2012)

Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back
por: Buscara, Laurine, et al.
Publicado: (2020)

Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials
por: Raupp-Barcaro, Inara F., et al.
Publicado: (2018)

Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome
por: Cannavo, Claudia, et al.
Publicado: (2022)

Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
por: Hwang, June Kyu, et al.
Publicado: (2020)

Alternative strategies in cardiac preclinical research and new clinical trial formats
por: Kreutzer, Fabian Philipp, et al.
Publicado: (2021)

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
por: Lui, Austin, et al.
Publicado: (2022)

Anticancer Drug Development: Preclinical Screening, Clinical Trials and Approval
por: Selwood, D
Publicado: (2004)

Preclinical Murine Models for Lung Cancer: Clinical Trial Applications
por: Kellar, Amelia, et al.
Publicado: (2015)

From Abnormal Hippocampal Synaptic Plasticity in Down Syndrome Mouse Models to Cognitive Disability in Down Syndrome
por: Cramer, Nathan, et al.
Publicado: (2012)

Oncolysis by paramyxoviruses: preclinical and clinical studies
por: Matveeva, Olga V, et al.
Publicado: (2015)

Preclinical and Clinical Antioxidant Effects of Natural Compounds against Oxidative Stress-Induced Epigenetic Instability in Tumor Cells
por: Bouyahya, Abdelhakim, et al.
Publicado: (2021)

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma
por: Lu, Xinjun, et al.
Publicado: (2023)

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
por: Camerino, Giulia Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j210sq0jjp99h5dfbne79ogv2j